Patrick O’Brien
Investor Relations Contact en PARDES BIOSCIENCES, INC. .
Perfil
Patrick O’Brien currently works at Pardes Biosciences, Inc., as Senior Vice President-Investor Relations.
Mr. O’Brien also formerly worked at Gilead Sciences, Inc., as Vice President-Investor Relations, Ligand Pharmaceuticals, Inc., as Investor Relations Contact, and Vir Biotechnology, Inc., as Investor Relations Contact.
Mr. O’Brien received his undergraduate degree from Loyola University New Orleans and Masters Business Admin degree from Kellogg School of Management.
Cargos activos de Patrick O’Brien
Empresas | Cargo | Inicio |
---|---|---|
PARDES BIOSCIENCES, INC. | Investor Relations Contact | - |
Antiguos cargos conocidos de Patrick O’Brien.
Empresas | Cargo | Fin |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Investor Relations Contact | - |
GILEAD SCIENCES, INC. | Investor Relations Contact | - |
LIGAND PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Formación de Patrick O’Brien.
Loyola University New Orleans | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Patrick O’Brien